Breaking News Instant updates and real-time market news.

NVO

Novo Nordisk

$40.95

-0.6433 (-1.55%)

, SNY

Sanofi

$38.22

0.03 (0.08%)

12:30
10/03/16
10/03
12:30
10/03/16
12:30

Novo Nordisk shifts to inventing new forms of insulin, WSJ says

Novo Nordisk (NVO), the global leader in insulin manufacturing, is delving into the expensive and complex business of inventing new forms of insulin, says the Wall Street Journal. The shift comes as the Danish company faces "intense competition" from the likes of rival Sanofi (SNY), added the Wall Street Journal. Reference Link

NVO

Novo Nordisk

$40.95

-0.6433 (-1.55%)

SNY

Sanofi

$38.22

0.03 (0.08%)

  • 07

    Oct

  • 30

    Oct

  • 06

    Nov

  • 29

    Mar

NVO Novo Nordisk
$40.95

-0.6433 (-1.55%)

09/09/16
JPMS
09/09/16
DOWNGRADE
JPMS
Neutral
Novo Nordisk downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Richard Vosser downgraded Novo Nordisk to Neutral saying additional upside is "hard to justify" given the more hostile U.S. pricing environment. The analyst sees a balanced risk/reward at current share levels.
09/12/16
DBAB
09/12/16
UPGRADE
DBAB
Buy
Novo Nordisk upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Tim Race upgraded Novo Nordisk to Buy saying the company's long-term prospects in diabetes are positive. Insulin price concerns in the U.S. are well known and reflected by the company's 24% share price decline year-to-date, Race tells investors in a research note. He has a DKK 360 price target for the shares.
09/13/16
EXAN
09/13/16
UPGRADE
EXAN
Outperform
Novo Nordisk upgraded to Outperform from Neutral at Exane BNP Paribas
09/23/16
PIPR
09/23/16
INITIATION
PIPR
Neutral
Novo Nordisk initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started Novo Nordisk with a Neutral rating and DKK 320 price target.
SNY Sanofi
$38.22

0.03 (0.08%)

09/09/16
LEER
09/09/16
NO CHANGE
LEER
Leerink updates therapeutics best ideas for 2016
In a note to investors this morning, Leerink has updated its best ideas for 2016 from the firm's five therapeutics analysts. The list includes Alexion (ALXN), Dermira (DERM), Intra-Cellular (ITCI), Sanofi (SNY), Allergan (AGN), Alnylam (ALNY), Innate Pharma (IPHYF), The Medicines Co. (MDCO), and Ophthotech (OPHT).
09/13/16
EXAN
09/13/16
UPGRADE
EXAN
Neutral
Sanofi upgraded to Neutral from Underperform at Exane BNP Paribas
09/23/16
PIPR
09/23/16
INITIATION
PIPR
Neutral
Sanofi initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Richard Purkiss started Sanofi with a Neutral rating and EUR 76 price target.
10/03/16
ROTH
10/03/16
NO CHANGE
Target $520
ROTH
Buy
Regeneron has 'solid' growth prospects, upside potential, says Roth Capital
After Regeneron (REGN) and Sanofi (SNY) released positive results from their Dupixent Phase 3 trials, SOLO 1 and SOLO in patients with atopic dermatitis, Roth Capital analyst Joseph Pantginis notes that clinical studies of Dupixent for additional atopic and allergic diseases are progressing and says he believes Regeneron's shares are poised for upside on upcoming catalysts. Moreover, the analyst says Regeneron has "solid" growth prospects based on approved and late stage products, deep pipeline, expansion of indications for current products, strong partners, and strong cash management. He reiterates a Buy rating and $520 price target on Regeneron's shares.

TODAY'S FREE FLY STORIES

KPLUF

K+S

12:07
06/29/17
06/29
12:07
06/29/17
12:07
Upgrade
K+S rating change  »

K+S upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$990.33

13.55 (1.39%)

, WFM

Whole Foods

$42.25

-0.31 (-0.73%)

12:06
06/29/17
06/29
12:06
06/29/17
12:06
Conference/Events
Deutsche Bank tech/food & retail analysts hold analyst/industry conference call »

Technology Analyst…

AMZN

Amazon.com

$990.33

13.55 (1.39%)

WFM

Whole Foods

$42.25

-0.31 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$1.87

0.039 (2.13%)

12:03
06/29/17
06/29
12:03
06/29/17
12:03
Hot Stocks
Bombardier Transportation reaches agreement on reorientation in Germany »

As part of the global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

12:00
06/29/17
06/29
12:00
06/29/17
12:00
Options
Active trading in VIX pit as the index spikes »

Active trading in VIX pit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$86.00

-2.09 (-2.37%)

11:55
06/29/17
06/29
11:55
06/29/17
11:55
Options
Salesforce put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:55
06/29/17
06/29
11:55
06/29/17
11:55
General news
Treasury Action: the long end of the curve remains weaker »

Treasury Action: the long…

NFX

Newfield Exploration

$28.45

0.89 (3.23%)

11:45
06/29/17
06/29
11:45
06/29/17
11:45
Options
Newfield Exploration call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

XLK

Technology Select Sector SPDR

$54.81

-0.96 (-1.72%)

, XLF

Financial Select Sector

$24.79

0.27 (1.10%)

11:38
06/29/17
06/29
11:38
06/29/17
11:38
Technical Analysis
Technical View: S&P 500 breaks 2420, bounces fractionally »

The S&P 500 (SPX)…

XLK

Technology Select Sector SPDR

$54.81

-0.96 (-1.72%)

XLF

Financial Select Sector

$24.79

0.27 (1.10%)

SPY

SPDR S&P 500 ETF Trust

$241.95

-1.54 (-0.63%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$91.56

1.7362 (1.93%)

11:30
06/29/17
06/29
11:30
06/29/17
11:30
Options
Bullish option play in JP Morgan as shares rally »

Bullish option play in JP…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

11:25
06/29/17
06/29
11:25
06/29/17
11:25
General news
Treasury announced a $72 B 3- and 6-month bill auction for Monday »

Treasury announced a $72…

INFO

IHS Markit

$45.05

-0.32 (-0.71%)

11:25
06/29/17
06/29
11:25
06/29/17
11:25
Conference/Events
The National Economists Club to hold a luncheon meeting Symbol changed to INFO IHS Markit »

National Economists Club…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

QVCA

QVC Group

$24.61

0.1 (0.41%)

, QVCB

QVC Group

11:25
06/29/17
06/29
11:25
06/29/17
11:25
Conference/Events
FBN Securities media analyst to hold a luncheon meeting »

Media Analyst Routh…

QVCA

QVC Group

$24.61

0.1 (0.41%)

QVCB

QVC Group

LVNTA

Liberty Ventures

$52.69

1.21 (2.35%)

GNCMA

General Communications

$36.81

0.97 (2.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 10

    Jul

ALRN

Aileron Therapeutics

11:23
06/29/17
06/29
11:23
06/29/17
11:23
Syndicate
Breaking Syndicate news story on Aileron Therapeutics »

Aileron Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

SHLD

Sears

$8.01

0.29 (3.76%)

11:22
06/29/17
06/29
11:22
06/29/17
11:22
Hot Stocks
Breaking Hot Stocks news story on Sears »

Returning to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:20
06/29/17
06/29
11:20
06/29/17
11:20
Hot Stocks
Breaking Hot Stocks news story on Sears »

Berkowitz says Fairholme…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABBV

AbbVie

$72.91

-0.01 (-0.01%)

11:20
06/29/17
06/29
11:20
06/29/17
11:20
Options
Abbvie attracts an opening call write »

Abbvie attracts an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:17
06/29/17
06/29
11:17
06/29/17
11:17
Hot Stocks
Real estate value the 'margin of safety' in Sears investment, Berkowitz says »

Bruce Berkowitz,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
06/29/17
06/29
11:17
06/29/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHLD

Sears

$8.01

0.29 (3.76%)

11:16
06/29/17
06/29
11:16
06/29/17
11:16
Hot Stocks
Berkowitz sees Sears net asset value at $90 per share »

Bruce Berkowitz of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
06/29/17
06/29
11:16
06/29/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOGL

Alphabet Class A

$961.01

12.92 (1.36%)

11:14
06/29/17
06/29
11:14
06/29/17
11:14
Technical Analysis
Technical View: Alphabet Class A has an active bearish pattern »

A bearish head and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BDRBF

Bombardier

$1.87

0.039 (2.13%)

11:13
06/29/17
06/29
11:13
06/29/17
11:13
Hot Stocks
Bombardier says Transportation restructuring costs included in previous guidance »

As part of the global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
6-Month Bill Announcement Offering Amount data reported »

6-Month Bill Announcement…

11:11
06/29/17
06/29
11:11
06/29/17
11:11
General news
3-Month Bill Announcement Offering Amount data reported »

3-Month Bill Announcement…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.